Dr. Chapa’s OBGYN Clinical Pearls

How do you diagnose vaginitis? Do you treat BV/yeast/trichomoniasis found on Pap smear? Do you use the Wet Prep, or molecular/DNA test? An ePub recently released in Obstetrics and Gynecology (the Green Journal), revealed some disappointing results for the Wet Prep. In the session, we will summarize key points from this article, as well as remind all of us of some key information released by the ACOG in January 2020 regarding vaginitis in the non-pregnant patient.

This session is a follow-up to our immediate pest episode. Are there any evidence-based true alternatives to the 50 g screening test for GDM? What about hemoglobin A-1 C? What about home blood glucose monitoring? Let’s dive into the data and see. We will also introduce you to… “Chapa chocolates”. 😳😊😆

It’s true, patients do NOT enjoy the 50 gram oral glucola test for gestational diabetes screening. And, the 100 gram test is even worse! Online sources claim that consuming a certain number of jellybeans is comparable to the standard screening/diagnostic test. Is that valid information? In this session we will review this jellybean theory and review what the data actually says.

The prevalence of Hepatitis C viral infection in pregnancy has doubled over the past 10 years. Active hepatitis C viral infection in pregnancy increases the risk for both maternal and neonatal morbidity. In the session, we will review this alarming trend along with key screening and management recommendations from the ACOG/CDC/SMFM.

In this episode, a simple to follow algorithm for management of APS in pregnancy will be presented. We will cover both antepartum and postpartum care.

Antiphospholipid syndrome has well established diagnostic criteria. Nonetheless, healthcare providers still find the condition- and it’s management-somewhat confusing. In this session, we will cover the diagnostic criteria for APS and who qualifies for investigation. In Part 2, we will cover specific management algorithms in pregnancy.

Fetal renal pelvic dilation occurs in 1% to 5% of all pregnancies. Although most are benign, it can be associated with genetic and structural disorders. Are you familiar with the CAKUT syndrome? When should Chromosomal MicroArray Analysis (CMA) be offered? What about prognosis? In the session, we will summarize and highlight the main points of the SMFM consult series #4 covering fetal renal pelvis dilation.

Just a quick message response for one of our listeners, Liane. Great points Liane… I take your message to heart! Here’s is our response. Thank you for being a contributing part of our listening family.

October is Domestic Violence Awareness month. This is such an important issue to discuss, and we will give into it here! Making her podcast debut is one of our residents, Dr. Katie Light. AND… as you will learn at the end of the podcast, she’s also a very proud Texas A&M Aggie! WHOOP.

Molnupiravir is now on the scene as a potential new therapy for mild to moderate COVID-19. As an oral administered medication, this could revolutionize care of the condition. In this session, we will review the early origins of this medication, its MOA, and what the data in the phase 3 study showed.